ACHN Stock UPDATES Achillion Pharmaceuticals (ACHN) 13.06 09/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Achillion Pharmaceuticals (ACHN) 13.06 $ACHN

'Mad Money' Lightning Round: I'm Taking Verizon Over AT&T
at The Street - Wed Sep 03, 5:00AM CDT
Cramer prefers Dow Chemicals to FMC and MGM Resorts to Las Vegas Sands.

Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
at The Street - Tue Sep 02, 6:49PM CDT
Investors are dumping the industrial and technology stocks in favor of anything domestic, including health care, transportation, restaurants and entertainment, Cramer says.

Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel
PR Newswire - Tue Sep 02, 7:55AM CDT
Today, Insiderslab.com revealed the latest insider trading research for Facebook (NASDAQ: FB), Plug Power (NASDAQ: PLUG), Achillion Pharmaceuticals (NASDAQ: ACHN), Apple (NASDAQ: AAPL), Twitter (NYSE: TWTR), and Intel (NASDAQ:INTC). US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results.

Four biotech takeover targets?
at Investor's Business Daily - Fri Aug 29, 5:58PM CDT
Following the news that Roche (RHHBY) is acquiring InterMune (ITMN) for $8.3 bil, other takeover talk has started to stir, leading to speculation that Achillion Pharmaceuticals (ACHN), Intercept Pharmaceuticals (ICPT), Puma Biotechnology (PBYI) and...

4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...

Most active Nasdaq-traded stocks
AP - Thu Aug 28, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 27, 9:32AM CDT
Roche's agreement to acquire InterMune has raised hopes for more such deals in the biotech sector.

The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology and Intercept Pharmaceuticals
PR Newswire - Wed Aug 27, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Roche (OTC:RHHBY-Free Report), InterMune (Nasdaq:ITMN-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Puma Biotechnology (NYSE BYI-Free Report) and Intercept Pharmaceuticals (Nasdaq:ICPT-Free Report).

Achillion Pharmaceuticals (ACHN) Jumps: Stock Adds 9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:37AM CDT
Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as the company saw its shares rise 9% on the day.

Nasdaq stocks posting largest percentage increases
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Achillion Pharmaceuticals (ACHN) Stock Hits New One-Year High
at The Street - Tue Aug 26, 11:10AM CDT
Achillion Pharmaceuticals (ACHN) touched another 52-week high of $12 on Tuesday after UBS tabbed the company as a possible takeover target.

3 Biotechs Surging Following InterMune Takeover - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 10:07AM CDT
InterMune 's (ITMN) impending acquisition by Roche (RHHBY) caused many mid-cap biotechs to rise.

Critical Alerts For Achillion Pharmaceuticals, Intel, YY, JA Solar and Skullcandy Released By InvestorsObserver
PR Newswire - Tue Aug 26, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACHN, INTC, YY, JASO and SKUL.

'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.

Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 25, 5:25PM CDT
The EMA accepted Cubist Pharmaceuticals' (CBST) MAA for its investigational antibiotic, ceftolozane/tazobactam.

More Biotech Mergers: Roche to Acquire InterMune (ITMN) - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Mon Aug 25, 3:43PM CDT
Roche is looking to buy InterMune, sending shares of ITMN up over 35 percent on the day.

Why Achillion Pharmaceuticals (ACHN) Stock Hit a One-Year High Today
at The Street - Mon Aug 25, 1:27PM CDT
Achillion Pharmaceuticals (ACHN) surged to a 52-week high of $11.15 in afternoon trading Monday after UBS tabbed the company as a possible takeover target.

Achillion Attains 52-Week High on ACH-3102 Patent Protection - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 4:00PM CDT
Achillion's (ACHN) shares touched a 52-week high of $10.18 on Aug 20 following its announcement that the USPTO has granted a patent to the company.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ATI's Financial Runway: $1.42B Sales and Rising

Updated Category News Views 12

ATI's Stellar Third Quarter: Beyond Expectations Today, ATI Inc. dropped a third-quarter performance that's got Wall Street abuzz—in a good way. The numbers speak volumes: ATI's sales soared by 26% to reach a cool $1.42 billion, smashing last year's results to bits. If you were banking on NYSE:ATI to keep your portfolio afloat, well, let's just say you're sitting...

Continue Reading
Hershey's Sweet Results: 2026 Earnings Soar

Updated Category News Views 75

Hershey's 2026 Q3 Financial Performance: A Closer Look At the end of September, The Hershey Company (NYSE: HSY) dished out some eye-popping numbers for their third quarter. With a net sales increase of 3.0%, they clocked in at $3,275.5 million. More importantly, earnings per share-diluted shot up by a whopping 111.8%, landing at $2.88. Clearly, Hershey’s strategic moves...

Continue Reading
Bugsy Siegel's Cold Case: Museum Exhibit Revisits Unsolved Murder

Updated Category News Views 189

Whoever thought sleuthing around organized crime’s dark corridors would land you inside Las Vegas' Mob Museum, tracing the cold case trail of none other than Bugsy Siegel? Yeah, the notorious mobster whose murder on June 20, 1947, has remained frozen in mystery like a stiff in cement shoes. Now, as we inch closer to the 80-year mark since Siegel was shot dead in Beverly...

Continue Reading
Armenia's Mining Sector Eyes Future Opportunities

Updated Category News Views 28

The Changing Landscape of Armenia's Mining Sector Crack open a map of Armenia, and you're staring at a mineral-rich ground ripe for opportunity. That's the lay of the land that the third annual Mining Armenia Forum 2026 zoomed in on, with more than 30 presentations tackling the future of responsible mining, investment, and technology. Taking over the mountain air in...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 99

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Spotting Alzheimer's: Holiday Visits Might Reveal More

Updated Category News Views 25

The Unspoken Truth of Holiday Reunions Is there any better barometer than a holiday visit to gauge how your parents are truly doing? Most of us are zooming in, lugging our baggage through the front door and finding Dad telling the same old story not once, not twice, but three solid times at the table. Then there’s Mom, fumbling her way through that pie recipe she could...

Continue Reading
Haier Biomedical's Strategic Expansion in the U.S.

Updated Category News Views 0

Nailing the U.S. Market with Cold Precision Haier Biomedical isn't just in the game to compete—they're setting the game rules with their mind-boggling expertise in blood management and pharmaceutical storage solutions. This October, they took center stage at the AABB and ISPE 2026 meetings, and they weren't messing around. Fresh Off the Exhibit Floor: Haier's Ambitions...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 77

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
Withings Sleep Care Service Tackles Post-Time Change Fatigue

Updated Category News Views 14

Counting Sheep: More Minutes or Just More Trouble? As Americans prepare for the clocks to fall back, many dream of an extra hour of sleep. But according to Withings, the reality is far less restful. Despite the clock change promising more shut-eye, folks average just 11 minutes extra sleep, only to watch that dissipate in the days following. Somehow, we lose more than we...

Continue Reading
IDrive Fortifies Data Protection with Top Certifications

Updated Category News Views 38

Ramping up Security in a Complex World Data protection isn’t just yesterday’s crucial task—it's today's battlefield and tomorrow's war. Companies like IDrive are stepping up to the plate, offering solutions that are as sturdy as a brick wall. In a world where data breaches and hackers lurk like wolves in the shadows, the demand for secure, compliant data protection...

Continue Reading

Top 5 Most Recently Viewed Articles

Powers Health Collaborates with Medline for Enhanced Supply Chain

Updated Category News Views 277

Powers Health Partners with Medline for Improved Efficiency Powers Health, a well-regarded integrated health system, is entering into a significant agreement with Medline, a top provider of medical-surgical products, to enhance efficiency across its operations. This partnership is expected to drive product and process standardization, which is crucial for delivering...

Continue Reading
New Addiction Training Program Aims to Transform Lives

Updated Category News Views 158

Understanding the enCompass Program and Its Impact on Stigma The enCompass program is an innovative initiative created by the Addiction Policy Forum, designed to combat the stigma surrounding addiction. This nonprofit organization aims to correct common misconceptions about addiction and equip family members with the necessary tools to support loved ones facing substance...

Continue Reading
Join the Celebration: Chile Wine Fest Returns to New York City

Updated Category News Views 285

Experience the Chile Wine Fest Coming to New York New York City is gearing up for an exciting event as the Chile Wine Fest returns, celebrating the delightful wines and culture of Chile. In collaboration with ProChile, this festival promises to be a memorable evening where wine lovers can gather, taste, and enjoy an array of culinary experiences. Location and Date Details...

Continue Reading
How a $1000 Investment in Fabrinet Could Have Grown Over 15 Years

Updated Category News Views 162

Understanding Fabrinet's Amazing Growth Fabrinet (NASDAQ: FN) has shown remarkable performance in the last 15 years, consistently outperforming the market. With an annualized return of 23.6%, this company stands as a beacon of successful investment strategy. Investment Breakdown: What Would $1000 Have Grown To? If you had invested $1000 into Fabrinet stock 15 years ago,...

Continue Reading
Georgia-Pacific Appoints David Neal to Transform Building Products

Updated Category News Views 400

David Neal Named Executive Vice President at Georgia-Pacific Georgia-Pacific has exciting news! David Neal, who has successfully led the company's gypsum division, has been appointed as the Executive Vice President of Building Products. This transition is set to occur early next month, marking a significant step in the company’s commitment to its growth and innovation...

Continue Reading